Proceedings to add, delete, or change the schedule of a drug or other substance may be initiated by the Drug Enforcement Administration (DEA), the Department of Health and Human Services (HHS), or by petition from any interested party, including:
The manufacturer of a drug
A medical society or association
A pharmacy association
A public interest group concerned with drug abuse
A state or local government agency
An individual citizen
Not quite unilateral, but seems like he could lean a bit on Becerra and get the re/de-scheduling started. Congress handed that authority to the executive branch years ago.
That is happening, maybe slower than any of us want ( and honestly probably time a bit to help in the election), but the rescheduling process had begun.
Proceedings to add, delete, or change the schedule of a drug or other substance may be initiated by the Drug Enforcement Administration (DEA), the Department of Health and Human Services (HHS), or by petition from any interested party, including:
The manufacturer of a drug
A medical society or association
A pharmacy association
A public interest group concerned with drug abuse
A state or local government agency
An individual citizen
Not quite unilateral, but seems like he could lean a bit on Becerra and get the re/de-scheduling started. Congress handed that authority to the executive branch years ago.
https://www.forbes.com/sites/sarahsinclair/2024/01/18/dea-considers-rescheduling-cannabis-what-this-means-for-us-and-global-reform/?sh=1ee5279b743f
That is happening, maybe slower than any of us want ( and honestly probably time a bit to help in the election), but the rescheduling process had begun.
Yes, they’ve said they’re looking into it like 3 times now.